Bullish option flow detected in Recursion Pharmaceuticals with 3,734 calls trading, 1.5x expected, and implied vol increasing over 8 points to 86.37%. Sep-24 7 calls and Sep-24 12 puts are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.54. Earnings are expected on August 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals put volume heavy and directionally bearish
- Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
- Cathie Wood’s ARK Investment bought 143K shares of Recursion Pharmaceuticals
- Cathie Wood’s ARK Investment bought 423K shares of Recursion Pharmaceuticals
- AI Could Revolutionize Drug Discovery: A Look at Key Players